ONSTORVIS Trademark

Trademark Overview

On Thursday, March 14, 2013, a trademark application was filed for ONSTORVIS with the United States Patent and Trademark Office. The USPTO has given the ONSTORVIS trademark a serial number of 85876474. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 31, 2016. This trademark is owned by Ikaria Therapeutics LLC. The ONSTORVIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical drugs for the treatment of hepatorenal syndrome (HRS)
onstorvis

General Information

Serial Number85876474
Word MarkONSTORVIS
Filing DateThursday, March 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 31, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2013

Trademark Statements

Goods and ServicesPharmaceutical drugs for the treatment of hepatorenal syndrome (HRS)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIkaria Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHampton, NJ 088279001
Party NameIkaria Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHampton, NJ 088279001

Trademark Events

Event DateEvent Description
Monday, October 31, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 31, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 25, 2016EXTENSION 5 GRANTED
Wednesday, March 23, 2016EXTENSION 5 FILED
Wednesday, March 23, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 19, 2015EXTENSION 4 GRANTED
Friday, September 18, 2015EXTENSION 4 FILED
Friday, September 18, 2015TEAS EXTENSION RECEIVED
Wednesday, April 22, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 25, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 24, 2015EXTENSION 3 GRANTED
Monday, March 16, 2015EXTENSION 3 FILED
Monday, March 16, 2015TEAS EXTENSION RECEIVED
Tuesday, September 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 22, 2014EXTENSION 2 GRANTED
Tuesday, September 9, 2014EXTENSION 2 FILED
Friday, September 19, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 9, 2014TEAS EXTENSION RECEIVED
Friday, March 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 12, 2014EXTENSION 1 GRANTED
Wednesday, March 12, 2014EXTENSION 1 FILED
Wednesday, March 12, 2014TEAS EXTENSION RECEIVED
Wednesday, February 26, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 24, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 10, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 24, 2013ASSIGNED TO EXAMINER
Wednesday, May 29, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 18, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

onstorvis syndrome hepatorenal treatment drugs pharmaceutical